Dec. 12, 2013
The University of Virginia School of Medicine has received a $3.3 million grant to research a way to dramatically increase the number of lungs that can be used for transplant.
The research seeks to use a drug developed at UVa. to rehabilitate lungs that are currently deemed unusable. It could allow doctors, for the first time, to harvest, repair and use lungs from donors whose hearts are not beating. It could also significantly increase the window of time when transplants are possible after lungs have been removed from the body, possibly allowing a patient in Miami to receive a lung from a deceased donor in Seattle.
“We want to be able to utilize the much larger pool of potential donor lungs: the non-heart-beating donors,” said co-principal investigator Victor Laubach, PhD, of UVa.’s Division of Thoracic and Cardiovascular Surgery. “And if we can do that using this system, we can significantly reduce or maybe even eliminate the wait list for transplants. And that would save a lot of lives.”
Only 15 percent of donor lungs now end up being usable, Laubach said. The rest are discarded because they’re deemed unsuitable, often because the donor died outside a hospital, causing an unknown amount of damage to the lungs.
“Fifteen percent is really a low, low number,” Laubach said. “That means there are a large number of patients on the waiting list for lungs, and many of those patients will die because they can’t get a lung in time.”
Researchers, led by Laubach and co-principal investigator Irving L. Kron, MD, are testing a drug, developed at UVa., in combination with an existing technology called ex-vivo lung perfusion. Ex-vivo lung perfusion allows a lung to be removed from the body, connected to a machine and evaluated to determine how well it can function. UVa.’s drug, meanwhile, has been shown to greatly reduce inflammation and damage to lungs in experimental transplantations. So the hope is that combining the two will allow doctors to rehabilitate and use lungs that now go to waste.
The five-year, $3.3 million grant, from the National Institutes of Health’s National Heart, Lung and Blood Institute, will allow the UVa. researchers to advance their studies, now using pigs, in hopes of one day applying the approach to humans.
The researchers also hope their work will extend the period that a lung is usable outside the body. Currently that window is typically six to eight hours; the UVa researchers hope to extend it to 24 hours or even longer.
The comments sections of Newsplex.com are designed for thoughtful, intelligent conversation and debate. We want to hear from our viewers, but we only ask that you use your best judgment. E-mail is required, but will not be displayed with comment.
As a host Newsplex.com welcomes a wide spectrum of opinions. However this is a site that we host. We have a responsibility to all our readers to try to keep our comment section fair and decent. For that reason The Newsplex reserves the right to not post or to remove any comment.
If you have any ideas to improve the conversation or this section let us know. Send an e-mail to email@example.com.
powered by Disqus